Literature DB >> 22464051

Red blood cell fatty acids are associated with depression in a case-control study of adolescents.

J V Pottala1, J A Talley, S W Churchill, D A Lynch, C von Schacky, W S Harris.   

Abstract

INTRODUCTION: Epidemiological studies suggest that reduced intakes and/or blood levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are associated with increased risk for depression in adults, but data on adolescents are scarce. The objective of this study was to determine whether red blood cell (RBC) levels of EPA+DHA (the omega-3 index) and/or the overall RBC fatty acid profile differ between depressed adolescents (cases) and non-depressed adolescents (controls). PATIENTS AND METHODS: We measured the RBC fatty acid composition of cases admitted to the hospital for depression (n=150) and compared it to that of controls (n=161).
RESULTS: Cases and controls had similar ages, gender proportions, and body mass index (BMI) distributions, but there was a significant difference in racial/ethnic composition due to differences in recruitment sites. The unadjusted odds ratio for case status was 0.72 (95% CI; 0.55-0.95) for a 1% absolute increase in the omega-3 index. A multivariable logistic regression model was used to determine which fatty acids were useful in classifying cases and controls; BMI, age, gender, and race/ethnicity were forced into the model. Seven fatty acids were selected (DHA, myristic, stearic, oleic, trans linoleic, trans palmitoleic, and alpha-linolenic acids) to optimize the model fit to the data. In the adjusted model, the odds ratio was 0.67 (95% CI; 0.49-0.93) for a 1 SD increase in DHA. Adding the seven fatty acid profile to the basic model increased the area under the ROC curve by 12.6% (7.5%-17.6%). DISCUSSION AND
CONCLUSION: These findings support the hypothesis that adolescent depression is associated with a perturbed RBC fatty acid pattern which includes a reduced omega-3 index. Intervention studies with EPA and DHA should be conducted in this vulnerable population for which few, safe therapeutic options currently exist.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22464051     DOI: 10.1016/j.plefa.2012.03.002

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  20 in total

Review 1.  Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology.

Authors:  Robert K McNamara; Jennifer J Vannest; Christina J Valentine
Journal:  World J Psychiatry       Date:  2015-03-22

2.  First-episode bipolar disorder is associated with erythrocyte membrane docosahexaenoic acid deficits: Dissociation from clinical response to lithium or quetiapine.

Authors:  Robert K McNamara; Ronald Jandacek; Patrick Tso; Thomas J Blom; Jeffrey A Welge; Jeffrey R Strawn; Caleb M Adler; Melissa P DelBello; Stephen M Strakowski
Journal:  Psychiatry Res       Date:  2015-10-09       Impact factor: 3.222

3.  Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker.

Authors:  Robert K McNamara; Ronald Jandacek; Patrick Tso; Thomas J Blom; Jeffrey A Welge; Jeffrey R Strawn; Caleb M Adler; Stephen M Strakowski; Melissa P DelBello
Journal:  Early Interv Psychiatry       Date:  2015-10-20       Impact factor: 2.732

Review 4.  Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical application.

Authors:  Erik Messamore; Daniel M Almeida; Ronald J Jandacek; Robert K McNamara
Journal:  Prog Lipid Res       Date:  2017-01-06       Impact factor: 16.195

5.  Genetic Variants of the FADS Gene Cluster Are Associated with Erythrocyte Membrane LC PUFA Levels in Patients with Mild Cognitive Impairment.

Authors:  J P Schuchardt; T Köbe; V Witte; J Willers; A Gingrich; V Tesky; J Pantel; D Rujescu; T Illig; A Flöel; A Hahn
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

Review 6.  The potential relevance of docosahexaenoic acid and eicosapentaenoic acid to the etiopathogenesis of childhood neuropsychiatric disorders.

Authors:  Alessandra Tesei; Alessandro Crippa; Silvia Busti Ceccarelli; Maddalena Mauri; Massimo Molteni; Carlo Agostoni; Maria Nobile
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-12-17       Impact factor: 4.785

7.  Omega-3 fatty acid biomarkers and subsequent depressive symptoms.

Authors:  Jane E Persons; Jennifer G Robinson; Eric M Ammann; William H Coryell; Mark A Espeland; William S Harris; JoAnn E Manson; Jess G Fiedorowicz
Journal:  Int J Geriatr Psychiatry       Date:  2013-12-11       Impact factor: 3.485

Review 8.  [Nutrition and mental diseases : Focus depressive disorders].

Authors:  L Libuda; J Antel; J Hebebrand; M Föcker
Journal:  Nervenarzt       Date:  2017-01       Impact factor: 1.214

9.  Role of Omega-3 Fatty Acids in the Etiology, Treatment, and Prevention of Depression: Current Status and Future Directions.

Authors:  Robert K McNamara
Journal:  J Nutr Intermed Metab       Date:  2016-05-04

10.  Detection and Treatment of Long-Chain Omega-3 Fatty Acid Deficiency in Adolescents with SSRI-Resistant Major Depressive Disorder.

Authors:  Robert K McNamara; Jennifer Strimpfel; Ronald Jandacek; Therese Rider; Patrick Tso; Jeffrey A Welge; Jeffrey R Strawn; Melissa P Delbello
Journal:  PharmaNutrition       Date:  2014-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.